HighTower Advisors’s DermTech, Inc. Common Stock DMTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-10,890
Closed -$7K 3976
2024
Q1
$7K Sell
10,890
-20
-0.2% -$23 ﹤0.01% 3422
2023
Q4
$18K Sell
10,910
-2,876
-21% -$4.2K ﹤0.01% 3406
2023
Q3
$19K Buy
13,786
+99
+0.7% +$248 ﹤0.01% 3333
2023
Q2
$36K Buy
13,687
+2,200
+19% +$6.58K ﹤0.01% 3200
2023
Q1
$42K Hold
11,487
﹤0.01% 3066
2022
Q4
$20K Sell
11,487
-50
-0.4% -$133 ﹤0.01% 3132
2022
Q3
$45K Buy
+11,537
New +$70.9K ﹤0.01% 2897
2022
Q2
Sell
-13,537
Closed -$198K 3612
2022
Q1
$198K Sell
13,537
-2,009
-13% -$26.9K ﹤0.01% 2847
2021
Q4
$246K Sell
15,546
-5,299
-25% -$127K ﹤0.01% 2612
2021
Q3
$668K Sell
20,845
-6,313
-23% -$222K ﹤0.01% 1882
2021
Q2
$1.13M Buy
27,158
+12,405
+84% +$510K ﹤0.01% 1562
2021
Q1
$749K Sell
14,753
-162,974
-92% -$8.52M ﹤0.01% 1738
2020
Q4
$5.75M Buy
+177,727
New +$2.52M 0.02% 548

Other funds holding DMTK

HighTower Advisors's DMTK Position: Q2 2024 in Review

HighTower Advisors sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2024, closing a stake of 10,890 shares — an estimated $7K sold.

HighTower Advisors first reported a position in DMTK in Q4 2020 and held it in 13 quarters. The position peaked at $5.75M in Q4 2020. 8 funds tracked by Wall St. Rank hold DMTK as of Q2 2024.

  • HighTower Advisors reported no remaining DermTech, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • HighTower Advisors sold 10,890 DermTech, Inc. Common Stock shares in Q2 2024, an estimated $7K.
  • HighTower Advisors first reported a position in DermTech, Inc. Common Stock in Q4 2020 and held it in 13 quarters.
  • HighTower Advisors's DermTech, Inc. Common Stock position peaked at $5.75M in Q4 2020.
  • 8 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2024.

Based on HighTower Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.